26 research outputs found
Erratum to: An interstitial deletion at 8q23.1-q24.12 associated with Langer-Giedion syndrome/ Trichorhinophalangeal syndrome (TRPS) type II and Cornelia de Lange syndrome 4
Cryptic genomic imbalances in patients with de novo or familial apparently balanced translocations and abnormal phenotype
<p>Abstract</p> <p>Background</p> <p>Carriers of apparently balanced translocations are usually phenotypically normal; however in about 6% of <it>de novo </it>cases, an abnormal phenotype is present. In the current study we investigated 12 patients, six <it>de novo </it>and six familial, with apparently balanced translocations and mental retardation and/or congenital malformations by applying 1 Mb resolution array-CGH. In all <it>de novo </it>cases, only the patient was a carrier of the translocation and had abnormal phenotype. In five out of the six familial cases, the phenotype of the patient was abnormal, although the karyotype appeared identical to other phenotypically normal carriers of the family. In the sixth familial case, all carriers of the translocations had an abnormal phenotype.</p> <p>Results</p> <p>Chromosomal and FISH analyses suggested that the rearrangements were "truly balanced" in all patients. However, array-CGH, revealed cryptic imbalances in three cases (3/12, 25%), two <it>de novo </it>(2/12, 33.3%) and one familial (1/12, 16.6%). The nature and type of abnormalities differed among the cases. In the first case, what was identified as a <it>de novo </it>t(9;15)(q31;q26.1), a complex rearrangement was revealed involving a ~6.1 Mb duplication on the long arm of chromosome 9, an ~10 Mb deletion and an inversion both on the long arm of chromosome 15. These imbalances were located near the translocation breakpoints. In the second case of a <it>de novo </it>t(4;9)(q25;q21.2), an ~6.6 Mb deletion was identified on the short arm of chromosome 7 which is unrelated to the translocation. In the third case, of a familial, t(4;7)(q13.3;p15.3), two deletions of ~4.3 Mb and ~2.3 Mb were found, each at one of the two translocation breakpoints. In the remaining cases the translocations appeared balanced at 1 Mb resolution.</p> <p>Conclusion</p> <p>This study investigated both <it>de novo </it>and familial apparently balanced translocations unlike other relatively large studies which are mainly focused on <it>de novo </it>cases. This study provides additional evidence that cryptic genomic imbalances are common in patients with abnormal phenotype and "apparently balanced" translocations not only in <it>de novo </it>but can also occur in familial cases. The use of microarrays with higher resolution such as oligo-arrays may reveal that the frequency of cryptic genomic imbalances among these patients is higher.</p
Combined 22q11.1-q11.21 deletion with 15q11.2-q13.3 duplication identified by array-CGH in a 6 years old boy
<p>Abstract</p> <p>Background</p> <p>Deletions of chromosome 22q11 are present in over 90% of cases of DiGeorge or Velo-Cardio-Facial syndrome (DGS/VCFS). 15q11-q13 duplication is another recognized syndrome due to rearrangements of several genes, belonging to the category of imprinted genes. The phenotype of this syndrome varies but has been clearly associated with developmental delay and autistic spectrum disorders. Co-existence of the two syndromes has not been reported so far.</p> <p>Results</p> <p>Here we report a 6-year-old boy presenting growth retardation, dysmorphic features and who exhibited learning difficulties. Fluorescence in situ hybridization (FISH) analysis of the proband revealed a deletion of DiGeorge Syndrome critical region (TUPLE). Array-CGH analysis revealed an interstitial duplication of 12 Mb in size in the area 15q11.2-q13.3, combined with a 3.2 Mb deletion at region 22q11.1-q11.21. FISH analysis in the mother showed a cryptic balanced translocation between chromosome 15 and chromosome 22 (not evident by classic karyotyping).</p> <p>Discusion</p> <p>The clinical manifestations could be related to both syndromes and the importance of array-CGH analysis in cases of unexplained developmental delay is emphasized. The present case further demonstrates how molecular cytogenetic techniques applied in the parents were necessary for the genetic counseling of the family.</p
An interstitial deletion at 8q23.1-q24.12 associated with Langer-Giedion syndrome/ Trichorhinophalangeal syndrome (TRPS) type II and Cornelia de Lange syndrome 4
ANTEPARTUM AMINOPHYLLINE TREATMENT FOR PREVENTION OF THE RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS
Sex-reversed phenotype in association with two novel mutations c.2494delA and c.T3004C in the ligand-binding domain of the androgen receptor gene
Objective: To establish the diagnosis of complete androgen insensitivity
syndrome (CAIS) in two patients with characteristic clinical and
hormonal findings, relative family history in one of them, and unusual
Mullerian remnants in the other.
Design: Case report.
Setting: Research laboratory in the Department of Medical Genetics at a
university children’s hospital.
Patient(s): Two patients with 46, XY sex reversal and two maternal aunts
of the first patient with the same clinical condition were tested.
Intervention(s): Bilateral gonadectomy was performed on both patients.
Main Outcome Measure(s): Genetic counseling, cancer prophylaxis, hormone
substitution therapy.
Result(s): Molecular analysis revealed two novel mutations, a frameshift
familial (c.2494delA) in patient 1 and a missense sporadic (c.T3004C) in
patient 2. The c.2494delA mutation was also detected in two of the three
affected maternal aunts of patient 1. Patient 2 presents an unusual
persistence of Mullerian structures.
Conclusion(s): Genetic counseling of potential women carriers of
androgen receptor (AR) mutations is crucial for the early diagnosis of
the affected offspring. The presence of Mullerian remnants, although
rare, should not exclude the diagnosis of CAIS. Both identified
mutations are novel and provide further evidence for the correlation
between specific AR mutations and phenotype. (Fertil Steril (R)
2008;90:2008.e1-e4. (C)2008 by American Society for Reproductive
Medicine.
Recommended from our members
Survivin regulation by HER2 through NF-κB and c-myc in irradiated breast cancer cells
Abstract Radiotherapy is an important treatment modality against cancer resulting in apoptosis and inhibition of cell growth. Survivin is an important cancer biomarker conferring to tumour cells increased survival potential by inhibiting apoptosis. In the present study, we investigated the implication of breast cancer cells features, as hormone receptors and p53 status, in the radio-resistance of breast cancer cells and in the regulation of survivin’s expression by nuclear factor (NF)-κB and c-myc. Six breast cancer cell lines Michigan Cancer Foundation (MCF-7), MCF-7/Human Epidermal Growth Factor Receptor (HER)2, M. D. Anderson – Metastatic Breast (MDA-MB-231), SK-BR-3, BT-474 and Human Breast Lactating (HBL-100) were irradiated and cell viability as well as cell cycle distribution were evaluated by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry, respectively. Survivin mRNA and protein levels were evaluated by real time PCR and Western blot analysis. Survivin and HER2 gene knockdown was performed with siRNA technology and investigation of transcription factors binding to survivin and c-myc gene promoters was assessed by chromatin immunoprecipitation. Student’s t-test and F-statistics were used for statistical evaluation. Our results demonstrated that only HER2+ breast cancer cells up-regulated survivin upon irradiation, whereas HER2 knockdown in HER2+ cells led to survivin’s down-regulation. Survivin and especially HER2 knockdown abolished the observed G2/M cell cycle checkpoint and reduced the radio-resistance of HER2 overexpressing breast cancer cells. Additionally, HER2 was found to regulate survivin’s expression through NF-κB and c-myc transcription factors. This study revealed the significance of HER2 in the radio-resistance of HER2+ breast cancer cells through induction of transcription factors NF-κB and c-myc, leading to activation of survivin, a downstream target oncogene preventing apoptosis
Genetic Polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women
Uridine diphospho-glucuronosyltransferase 1 (UGT1A1) is involved in
estradiol glucuronidation, which may play a central role in the etiology
of breast cancer. A common insertion/ deletion polymorphism in the
TATAA-box of the promoter region of UGT1A1 results in decreased
initiation of transcription, and has been associated with breast cancer
risk in different ethnic groups. In the present study, the role of the
above genetic variation at the UGT1A1 locus in breast cancer
susceptibility was investigated in a homogeneous population. Our
case-control study included 136 women with breast cancer and 186 healthy
female controls of Greek origin. The polymorphism A(TA) nTAA in the
promoter region of UGT1A1 gene was studied using the Fragment Analysis
Software of an automated DNA sequencer and three genotypes (homozygous
7/ 7, heterozygous 6/ 7, and normal homozygous 6/ 6) were identified. No
significant associations were observed between the 7/ 7 genotype and
breast cancer risk, indicating that further studies in Caucasian women
are needed to elucidate the role of UGT1A1 polymorphism in breast cancer
risk
Gilbert Syndrome as a Predisposing Factor for Cholelithiasis Risk in the Greek Adult Population
We investigated the hypothesis that coinheritance of the common
A(TA)(n)TAA promoter mutation at the UGT1A1 locus associated with
Gilbert syndrome is a risk factor for gallstone formation in a
homogeneous adult population, by conducting a case-control study that
included 198 adult patients with cholelithiasis and 152 healthy controls
both of Greek origin. Three genotypes were found: 7/7 (17.8% in
controls and 23.3% in patients), 6/7 (33.5% in controls and 46.5% in
patients), and normal homozygous 6/6 (48.7% in controls and 30.3% in
patients). The Gilbert UGT1A1 genotypes 6/7 and 7/7 show significant
association (odds ratio 2.225, 95% confidence interval 1.373-3.605, p =
0.001, and odds ratio 2.101, 95% confidence interval 1.171-3.770, p =
0.013, respectively) with cholelithiasis risk. This association supports
the theory that genetic factors are responsible for a fraction of
symptomatic gallstone disease; however, further studies are required in
different ethnic groups to fully elucidate the involvement of Gilbert
syndrome in gallstone disease